Sign in

NCT06457139Completed

Preventing T2DM After GDM With Immediate Postpartum Screening

Preventing Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus With Immediate Postpartum Screening

Source: ClinicalTrials.gov · Last updated 14 Aug 2026

Brief summary (registry, in English)

The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.

Status (registry)
Completed
Study type
Interventional
Enrollment
116 (actual)
First submitted
6 Jun 2024
Start date
1 Jun 2025
Primary completion date
31 Jul 2026
Lead sponsor
University of Massachusetts, Worcester
NCT number
NCT06457139

What you commit to

  • Study type: Interventional
  • Participants enrolled: 116
  • From 1 Jun 2025 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • systemic steroid use

Other illness

  • known diagnosis of pre-existing pre-gestational diabetes in pregnancy

Lab values

  • inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum

Who the study is looking for

  • pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
  • receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
  • able and willing to provide informed consent
  • ability to complete immediate in hospital postpartum glucose testing
  • have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Massachusetts Memorial Medical Center
Coordinator of this site? Confirm its status
WorcesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.